Alex discusses the challenges of drug regulation, highlighting the delicate balance between safety and urgency in bringing new drugs to market. He emphasizes the importance of considering disease severity when setting regulatory burdens and shares insights from past experiences, like the AIDS epidemic, where patient advocacy influenced regulatory decisions.
